| NETHERLANDS | WP2 | |||
| Organization | UMCG | |||
| Name of cohort | COVID-19 in patients admitted to the intensive care | |||
| Referring partner | UMCG | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | UMCG Groningen, Netherlands | ||
| Time of data collection | 03/2020 | 01/2022 | ||
| Enrolment | Inactive | |||
| Study setting | Single center | |||
| Population | Age | Adults,Elderly | ||
| Type | Retrospective | |||
| Total number of patients | 397 | |||
| Site of enrolment (WP2) | Outpatient,Inpatient,ICU | |||
| Data collection | Clinical data | True | ||
| Serological data | False | |||
| Genetic data | True | |||
| Sample collection | True | |||
| Sample collected | Whole blood | No | ||
| PBMC | No | |||
| Dry-spot blood | No | |||
| Plasma | No | |||
| Serum | No | |||
| Stool | No | |||
| NP swabs | Yes | |||
| Other | None | |||
| Description | The 1500 NP study at the UMCG includes adult patients admitted to the intensive care in the University Medical Center Groningen during the period of March 2020 to January 2022 as well as patients with mild and moderated symptoms during multiple waves of the SARS-CoV-2 pandemic. Clinical data and biweekly SARS-CoV-2 dynamics. | |||